ASEAN stockpiles bird flu drug in Malaysia The Association of South East Asian Nations.

ASEAN in addition has promised to work more closely on tackling cross-border threats such as bird flu by developing a regional approach and by sharing assets. Malaysian Primary Minister Abdullah Ahmad Badawi offers said the region must be in circumstances of preparedness, and added that the stockpile would be available to any ASEAN country that might require it. Related StoriesHigh dosage flu vaccines reduce hospitalization risk during influenza seasonTaking methods to prevent significantly, drive back fluFlu vaccine significantly decreases stroke riskAlthough bird flu virus remains relatively hard for people to catch and is usually pass on almost exclusively through individual contact with birds, health officials fear it could mutate right into a virus that could move from individual to individual and established off a global pandemic. Continue reading

Cross posted from Character&8217.

The increased loss of female income will probably have a greater effect on welfare, as women tend to spend a greater proportion of their income on interacting with the basic needs of family members, IPS writes. Heyzer stated, A woman’s face continues to be the picture of poverty . This article is definitely republished with kind authorization from our close friends at The Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Survey, search the archives, or sign up for email delivery of in-depth coverage of health policy developments, debates and discussions. The Kaiser Daily Health Policy Report is published for, a free of charge provider of The Henry J. Continue reading

AGTR2 gene variant predicts risk for preeclampsia By Helen Albert.

Predicated on the company’s strong performance year-to-date, and the outlook for the rest of the year, Abbott is raising both its product sales growth and earnings-per-talk about forecasts for the full-year 2008. The business is increasing its earnings-per-share guidance range for the full-season from $3.20 – $3.25 to $3.24 – $3.28, excluding specified items, the midpoint which reflects growth of approximately 15 %. In addition, the company is raising its sales forecast to mid-teens development for the entire year. For the very first time, Abbott offers earnings-per-share guidance for the third-quarter 2008 of $0.76 – $0.78, excluding specified items, the midpoint of which reflects growth of around 15 %. Continue reading

A privately held proteins diagnostic and therapeutic discovery organization.

Tau stabilizes proteins that are in charge of the transport and framework in neuronal cells. Abnormal accumulation of changed tau protein is a respected indicator in a number of neurodegenerative conditions including Alzheimer's Disease, Progressive Supranuclear Palsy and Corticobasal Degeneration. In these conditions, the development of tau pathology highly correlates with medical disease progression. ‘The necessity for new approaches and therapies to handle Alzheimer's disease is critical,’ said Jim Sullivan, Ph.D., vice president, pharmaceutical discovery, AbbVie. Continue reading

60 % of young Americans plan to purchase a gun to safeguard their future homes.

60 % of young Americans plan to purchase a gun to safeguard their future homes, families President Obama and best Democrats in Congress have made it quite clear in recent days: They need massive brand-new gun bans and also, they want to know very well what kind of guns you have previously, and how many ed treatment . Those others and demands are contained in fresh legislation proposed by Sen. Dianne Feinstein, D-Calif., Jan. 24. If passed, her bill would ban ratings of firearms including semi-automatic rifles, some handguns and certain types of shotguns aswell. Continue reading

Adult hospitalizations for congenital cardiovascular disease increasing.

Adult hospitalizations for congenital cardiovascular disease increasing, researchers find Jared M. O'Leary, M.D., of Women&# and Brigham;s Hospital, Boston, and co-workers analyzed U.S. Hospitalizations from 1998 through 2010 for children and adults with congenital cardiovascular disease. There are more than 787,000 adults with congenital heart disease in the usa. Adults with congenital cardiovascular disease stay at risk for frequent hospitalizations, the authors write in a Research Letter published on-line by JAMA to coincide using its display at the American University of Cardiology's annual Scientific Classes. The experts identified congenital heart disease admissions to acute care hospitals from 1998 through 2010 using the Nationwide Inpatient Sample, a stratified 20 % sample of hospitalizations, including approximately 8 million admissions yearly from approximately 1,000 hospitals. Continue reading

Preventing Childhood Weight problems: A National Conference Focusing on Being pregnant.

The %age of children ages 6 to 11 who are over weight improved from 4 % in the 1970s to 15 % in 1999-2000. Related StoriesStressed Latino parents twice as likely to have children with obesityAustralian researchers define key features of metabolically healthful obeseHSS researchers help identify lupus sufferers at increased threat of problem pregnanciesStudies offered at the conference showed a child’s size at birth and early diet plan may affect body mass and weight gain. Such critical intervals, according to researchers, should be the concentrate of childhood obesity prevention efforts. While large for gestational age group infants are more vunerable to high excess weight or high body mass index afterwards in life, these infants have a larger proportion of lean tissue relative to body fats and a lesser risk of cardiovascular disease, stroke, hypertension, and type 2 diabetes at confirmed BMI. Continue reading

So how will rheumatologists select a biologic agent for individuals with so many products available?

The surveyed rheumatologists are thrilled to have a brand-new biologic agent that provides a unique mechanism of action and every among the respondents intends to use Actemra in their practice although the timeframe for adoption will vary. So how will rheumatologists select a biologic agent for individuals with so many products available? The full report will end up being released on March 12th and two subsequent waves of study are planned to monitor uptake at three months and half a year post launch. Continue reading

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen Akcea Therapeutics.

People who have FCS cope with daily implications of their disease, including persistent abdominal pain and life-altering food restrictions. Unfortunately, current treatment plans do not reduce triglyceride levels enough to reduce the chance of serious disease in individuals with FCS, said Paula Soteropoulos, President and CEO at Akcea Therapeutics. Orphan medication designation for FCS underscores the necessity for improved therapies to treat individuals with FCS and can be an essential benchmark as we complete the ongoing Phase 3 study in patients with FCS and plan commercialization. Continue reading

Representing 75.

The Academy also endorses medical liability reform that treats both individuals and suppliers equitably and encourages healthcare specialists to apologize for adverse outcomes without increasing risk, and sustainable funding and payment mechanisms that consider comparative effectiveness information.. AAPA applauds Baucus’ attempts to move forward on health care reform legislation The American Academy of Physician Assistants , representing 75,000 clinically practicing physician assistants in the United States, is quite pleased that America’s Healthy Future Act of 2009, produced yesterday by Senator Max Baucus, fully integrates PAs into new team-based models of care that are designed to promote primary care and the coordination of look after patients with chronic medical conditions. Continue reading

4SCs vidofludimus Phase IIa study in IBD meets primary endpoint 4SC AG.

4SC’s vidofludimus Phase IIa study in IBD meets primary endpoint 4SC AG , a drug discovery and development company focused on autoimmune and cancers indications, today declared positive preliminary results of a Stage IIa study in inflammatory bowel disease using its lead autoimmune compound vidofludimus, an oral inhibitor of interleukin-17 release. The exploratory, open-label, single-arm Phase IIa ENTRANCE study met its major endpoint of significantly increasing the response price in corticosteroid-dependent IBD sufferers to 88.5 percent versus an average placebo response across released benchmark clinical trials of around 20 percent . Continue reading

Page 3 of 18812345678...203040...Last »